Maicelium Biomaterials

Transforming industrial waste into high-value biopolymers by harnessing the properties of mycelium – the root structure of fungi.

Industrial Technologies
Active
Pre-Funding Rehovot, Israel Founded 2024
Last updated 2026-07-20
Total raised
Last: Grant 2024-05
Stage
Pre-Funding
Founded
2024
Headcount
2
HQ
Rehovot, Israel
Sector
Industrial Technologies

About

Maicelium Biomaterials is an innovator in the biopolymer industry, delivering a biodegradable, circular, and superior alternative to petroleum-based plastics. The company leverages the properties of mycelium, the "root" structure of fungi, to transform industrial waste into high-value biopolymers. Their technology accelerates mycelium's natural ability to synthesize biodegradable and superior alternatives to petroleum-based plastics, providing sustainable materials for industries such as cosmetics, food packaging, and personal care. Their customizable biopolymers offer eco-friendly solutions that reduce reliance on traditional plastics while addressing environmental concerns.

Funding history · 1 round · — total

2024-04
Grant Undisclosed

Headcount over time

From 6 (2023-07) to 1 (2026-01) · -5 (-83%) · 5 points · source: Finder history + radar grounding
60 2023-07 2026-01

Q&A

What is Maicelium Biomaterials' primary focus?
Maicelium Biomaterials focuses on transforming industrial waste into high-value biopolymers by utilizing mycelium, the root structure of fungi, to create sustainable alternatives to petroleum-based plastics.
When was Maicelium Biomaterials founded?
Maicelium Biomaterials was founded in May 2024.
How many employees does Maicelium Biomaterials currently have?
Maicelium Biomaterials has 1-10 employees.
What was Maicelium Biomaterials' most recent funding round?
In May 2024, Maicelium Biomaterials secured a Grant round with i4Valley.
Who is the CEO of Maicelium Biomaterials?
Ido Cohen is the CEO and a founder of Maicelium Biomaterials.
In which sector does Maicelium Biomaterials primarily operate?
Maicelium Biomaterials operates primarily in the Industrial Technologies sector, with a focus on Material Innovations & Applications and Climate Tech.
What kind of business model does Maicelium Biomaterials employ?
Maicelium Biomaterials operates on a B2B business model.
What is the current product stage of Maicelium Biomaterials?
Maicelium Biomaterials is currently in the R&D product stage.

Team · 2

Ido Cohen
Founder · CEO
Dr. Yochai
Founder · CTO

Sectors & technology

Primary sector
Industrial Technologies
Sub-sectors
Industrial TechnologiesMaterial Innovations & ApplicationsClimate TechClean Industry Tech Sustainable Materials & Circularity
Technologies
Biologicals
Target customers
Industrial ManufacturingAgriculture & Food
Business model
B2B

Highlights

Climate Tech

Tags

packaging-and-containersclimate-techbiotechnologyconstruction-materialswaste-managementbiomaterialsmaterialsfungi
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)

External links

Websitemaicelium.com/
LinkedInlinkedin.com/company/96374426

Identifiers & details

Founded2024-5
Employees (exact)2

Radar intelligence

Web history (Wayback)

Domainmaicelium.com

Certificate / subdomain footprint

Subdomains3

Israeli Companies Registrar (רשם החברות / ICA)

Registrar # (ח.פ.)516976560
Statusפעילה
Corp typeישראלית חברה פרטית
Incorporated2024-05-01
Purposeלעסוק בכל עיסוק חוקי
Liabilityמוגבלת
In violation (unfiled)yes
Active charges / liens0
Registry events1 — violation (1)
Registered addressהמגילה 63 ראשון לציון

Recent registry events

DateEvent
2026-06-25עדכון הפרה